Melatonin for treating sleep disorders in adults who are blind (ES38)
Summary of the evidence on melatonin for treating sleep disorders in adults who are blind
Search results
198 results
-
-
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia (ES37)
Summary of the evidence on delafloxacin for community-acquired pneumonia in adults
-
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults (ES40)
Summary of the evidence on eravacycline for complicated intra-abdominal infections in adults
-
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)
Summary of the evidence on oritavancin for acute bacterial skin and skin structure infections (ABSSSI) in adults
-
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia (MIB278)
NICE has developed a medtech innovation briefing (MIB) on clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia
-
CerebAir for continuous EEG monitoring in intensive care (MIB279)
NICE has developed a medtech innovation briefing (MIB) on CerebAir for continuous EEG monitoring in intensive care
-
d-Nav insulin management app for type 2 diabetes (MIB285)
NICE has developed a medtech innovation briefing (MIB) on d-Nav insulin management app for type 2 diabetes
-
MMprofiler for prognostic risk classification in multiple myeloma (MIB270)
NICE has developed a medtech innovation briefing (MIB) on MMprofiler for prognostic risk classification in multiple myeloma
-
Patient Status Engine for wireless monitoring of vital signs (MIB271)
NICE has developed a medtech innovation briefing (MIB) on the Patient Status Engine for wireless monitoring of vital signs
-
Lung texture analysis for measuring interstitial lung diseases (MIB272)
NICE has developed a medtech innovation briefing (MIB) on lung texture analysis for measuring interstitial lung diseases
-
Immunoscore for predicting risk of colon cancer relapse (MIB269)
NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse
-
GaitSmart assessment and vGym personalised exercise rehabilitation programme for people with gait and mobility issues (MIB283)
NICE has developed a medtech innovation briefing (MIB) on GaitSmart assessment and vGym personalised exercise rehabilitation programme for people with gait and mobility issues
-
AposHealth for knee osteoarthritis (MIB284)
NICE has developed a medtech innovation briefing (MIB) on AposHealth for knee osteoarthritis
-
Lumella point-of-care test for assessing pre-eclampsia risk (MIB287)
NICE has developed a medtech innovation briefing (MIB) on Lumella point-of-care test for assessing pre-eclampsia risk
-
HealthVCF for detecting vertebral compression fractures on CT scans (MIB267)
NICE has developed a medtech innovation briefing (MIB) on HealthVCF for detecting vertebral compression fractures on CT scans
-
trublood-prostate for triaging and diagnosing people with prostate cancer symptoms (MIB268)
NICE has developed a medtech innovation briefing (MIB) on trublood-prostate for triaging and diagnosing people with prostate cancer symptoms
-
Personal KinetiGraph for remote clinical management of Parkinson's disease (MIB258)
NICE has developed a medtech innovation briefing (MIB) on Personal KinetiGraph for remote clinical management of Parkinson’s disease
-
WoundExpress to manage lower leg wounds (MIB261)
NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds
-
Smart Peak Flow for monitoring asthma (MIB282)
NICE has developed a medtech innovation briefing (MIB) on Smart Peak Flow for monitoring asthma
-
Paige Prostate for prostate cancer (MIB280)
NICE has developed a medtech innovation briefing (MIB) on Paige Prostate for prostate cancer
-
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)
NICE has developed a medtech innovation briefing (MIB) on FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress
-
RapidAI for analysing CT/MRI brain scans in people with suspected acute stroke (MIB262)
NICE has developed a medtech innovation briefing (MIB) on RapidAI for analysing CT/MRI brain scans in people with suspected acute stroke
-
Magtrace and Sentimag for locating sentinel lymph nodes (MIB263)
NICE has developed a medtech innovation briefing (MIB) on Magtrace and Sentimag for locating sentinel lymph nodes
-
SYNE-COV for predicting COVID-19 outcomes (MIB264)
NICE has developed a medtech innovation briefing (MIB) on SYNE-COV for predicting COVID-19 outcomes
-
AI technologies for detecting diabetic retinopathy (MIB265)
NICE has developed a medtech innovation briefing (MIB) on AI technologies for detecting diabetic retinopathy
-
Acumen IQ sensor for predicting hypotension risk (MIB266)
NICE has developed a medtech innovation briefing (MIB) on Acumen IQ sensor for predicting hypotension risk
-
SecurePort IV tissue adhesive for use with percutaneous catheters (MIB288)
NICE has developed a medtech innovation briefing (MIB) on SecurePort IV tissue adhesive for use with percutaneous catheters
-
YOURmeds for medication support in long-term conditions (MIB289)
NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions
-
Artificial intelligence for analysing chest X-ray images (MIB292)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing chest X-ray images
-
Genedrive MT-RNR1 ID System for detecting single nucleotide polymorphism m.1555A G in newborn babies (MIB290)
NICE has developed a medtech innovation briefing (MIB) on Genedrive MT-RNR1 ID System for detecting single nucleotide polymorphism m.1555A>G in newborn babies
-
icobrain ms for active relapsing–remitting multiple sclerosis (MIB291)
NICE has developed a medtech innovation briefing (MIB) on icobrain ms for active relapsing–remitting multiple sclerosis
-
PLASMA system with button electrode for electrovaporisation of the prostate (MIB274)
NICE has developed a medtech innovation briefing (MIB) on PLASMA system with button electrode for electrovaporisation of the prostate.
-
OrganOx metra for liver transplant (MIB275)
NICE has developed a medtech innovation briefing (MIB) on OrganOx metra for liver transplant
-
Carnation Ambulatory Monitor for ambulatory detection of cardiac arrythmias (MIB276)
NICE has developed a medtech innovation briefing (MIB) on Carnation Ambulatory Monitor for ambulatory detection of cardiac arrythmias
-
Colli-Pee for first void urine collection (MIB273)
NICE has developed a medtech innovation briefing (MIB) on Colli-Pee for first void urine collection
-
24/7 EEG SubQ for epilepsy (MIB277)
NICE has developed a medtech innovation briefing (MIB) on 24/7 EEG SubQ for epilepsy
-
The Insides System for managing intestinal failure (MIB286)
NICE has developed a medtech innovation briefing (MIB) on The Insides System for managing intestinal failure
-
Bladder EpiCheck for detecting bladder cancer recurrence (MIB293)
NICE has developed a medtech innovation briefing (MIB) on Bladder EpiCheck for detecting bladder cancer recurrence
-
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas (MIB294)
NICE has developed a medtech innovation briefing (MIB) on AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas
-
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions (MIB295)
NICE has developed a medtech innovation briefing (MIB) on ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions
-
Granulox for managing chronic non-healing wounds (MIB296)
NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds
-
The percentage of patients on the CKD register whose notes have a record of a urine albumin:creatinine ratio (or protein:creatinine ratio) test in the preceding 12 months
The percentage of patients on the CKD register whose notes have a record of a urine albumin:creatinine ratio (or protein:creatinine ratio) test in the
-
The contractor establishes and maintains a register of patients aged 18 years or over with CKD with classification of categories G3a to G5 (previously stage 3 to 5)
NICE indicators. NM83 chronic kidney disease guidance.
-
The percentage of patients with diabetes, on the register, in whom the last blood pressure reading (measured in the preceding 12 months) is 140/80 mmHg or less
NICE indicators. NM02 Diabetes guidance.
-
The percentage of patients registered at the practice aged 65 years and over who have been diagnosed with one or more of the following conditions: coronary heart disease, heart failure, hypertension, diabetes, CKD, PAD, or stroke/TIA who have had a pulse rhythm assessment in the preceding 12 months.
The percentage of patients registered at the practice aged 65 years and over who have been diagnosed with one or more of the following conditions:...
-
The proportion of pregnant women having a planned caesarean section who have the procedure carried out at or after 39 weeks 0 days
The proportion of pregnant women having a planned caesarean section who have the procedure carried out at or after 39 weeks 0 days
-
Proportion of pregnant women accessing antenatal care who are seen for booking by 10 weeks and 0 days
Proportion of pregnant women accessing antenatal care who are seen for booking by 10 weeks and 0 days Subject(s): Pregnancy and neonates
-
The proportion of pregnancies resulting in a neonatal death or still birth
The proportion of pregnancies resulting in a neonatal death or still birth Subject(s): Pregnancy and neonates, Mortality
-
The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 12 months
NICE indicators. NM39 smoking cessation.
-
The contractor supports patients who smoke in stopping smoking by a strategy which includes providing literature and offering appropriate therapy
The contractor supports patients who smoke in stopping smoking by a strategy which includes providing literature and offering appropriate therapy